Category Archives: Drug News

Radicava Infusion

Infusion Plus, Inc is now infusing Radicava! This drug was first approved by the FDA in May, 2017. It is the first treatment option approved in more than twenty years for ALS otherwise known as Amyotrophic Lateral Sclerosis or Lou Gehrig’s Disease. In clinical trials, there was a decline in… Read More »

First Dose

At this time, Infusion Plus, Inc.  does not first dose an intravenous therapy in the patient’s home.  It is the decision of the Director of Operations to serve our mutual patients and your pharmacy with optimum safety. Infusion Plus, Inc. will first dose a patient in a physician’s office or… Read More »